Boulder Diagnostics Licenses Novel Lyme Disease Diagnostic Technology from Radboud University Nijmegen Medical Centre, The Netherlands

Published: Jan 05, 2012

BOULDER, Colo. & NIJMEGEN, the Netherlands--(BUSINESS WIRE)--Boulder Diagnostics Inc. and the Department of Internal Medicine, Radboud University Nijmegen Medical Centre (RUNMC) announced today the entry into a license and collaboration agreement to market the innovative Lyme disease diagnostic test developed at RUNMC. Under the agreement Boulder will finance further research at the Department of Internal Medicine, and RUNMC will be entitled to royalties on future sales of the licensed technology. Further details were not disclosed.

Back to news